Investment Summary

Gilde Healthcare Invests In Nizo

On March 7, 2016, private equity firm Gilde Healthcare invested in life science company Nizo

Investment Highlights
  • This is Gilde Healthcare’s 19th transaction in the Life Science sector.
  • This is Gilde Healthcare’s 12th transaction in the Netherlands.

Investment Summary

Date 2016-03-07
Target Nizo
Sector Life Science
Investor(s) Gilde Healthcare
Deal Type Growth Capital

Target

Nizo

Ede, Netherlands
Nizo is a state-of-the art, globally operating contract research organization for better food and health. NIZO focuses on the development and application of innovative technologies for its customers in the global food industry and related markets, including plant protein transition, fermentation technologies and pilot plant facilities. Research in health and food are converging, with the pharmaceutical industry looking at effects of food components and the food sector becoming more aware of the health effects of their products. Nizo was founded in 1948 and is based in Ede, Netherlands.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Gilde Healthcare

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1982
PE ASSETS 2.6B EUR
Size Large
Type Sector Focused
DESCRIPTION

Gilde Healthcare is a specialist private equity and venture investor focused on the healthcare sector. The Firm's buyout group targets majority investments throughout Europe (preference for Germany, the Netherlands, Belgium, Austria or Switzerland) and has a focus on healthcare providers, suppliers and service providers active in the healthcare market. The Firm's venture group looks to invest in early stage medtech, diagnostics, digital health and therapeutics companies throughout North America and Europe. Gilde Healthcare was established in 1982 and is headquartered in Utrecht, Netherlands.


DEAL STATS #
Overall 36 of 55
Sector: Life Science M&A 19 of 26
Type: Growth Capital M&A Deals 5 of 7
Country: Netherlands M&A 12 of 21
Year: 2016 M&A 2 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-01-01 RAD-x

Mannheim, Germany

RAD-x is a platform for the creation of pan-European operator of medical service companies that are active in the fields of diagnostic imaging and nuclear medicine. RAD-x was founded in 2016 and is based in Mannheim, Germany.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-04-11 STAT-Dx Life S.L.

Barcelona, Spain

STAT-Dx Life S.L. is a developer of multiplex diagnostics for one-step, fully integrated molecular analysis of common syndromes. STAT-Dx Life S.L. was established in 2010 and is based in Barcelona, Spain.

Buy -